Pedro E. Cruz
Impact in
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Psychiatry top 2%
Papers in
- Co-authors
- Manuel J.T. CarrondoPaula M. AlvesTodd E. GoldeTerence R. FlotteAwilda M. RosarioCarolina Ceballos‐DiazParamita ChakrabartyCristina Peixoto
- Journals
- Human Gene Therapy (5 papers)Journal of Biotechnology (5 papers)Molecular Therapy (5 papers)Biotechnology Progress (5 papers)Biotechnology and Bioengineering (4 papers)
- Partner nations
- United StatesPortugalGermany
In The Last Decade
Pedro E. Cruz
123 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 136
- Neurology 581
- Biological Psychiatry 147
- Genetics 588
- Physiology 878
- Genetics 907
Countries citing papers authored by Pedro E. Cruz
This map shows the geographic impact of Pedro E. Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro E. Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro E. Cruz more than expected).
Fields of papers citing papers by Pedro E. Cruz
This network shows the impact of papers produced by Pedro E. Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro E. Cruz. The network helps show where Pedro E. Cruz may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro E. Cruz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 12 | |
| 7 | 2018 | 104 | |
| 8 | 2016 | 92 | |
| 9 | 2015 | 44 | |
| 10 | A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo | 2015 | 1 |
| 11 | 2014 | 32 | |
| 12 | 2013 | 132 | |
| 13 | 2013 | 61 | |
| 14 | 2010 | 27 | |
| 15 | 2008 | 11 | |
| 16 | 2007 | 44 | |
| 17 | 2007 | 11 | |
| 18 | 2007 | 5 | |
| 19 | 2004 | 25 | |
| 20 | Herpes Simplex Virus DNA as a Potential DNA Vaccine | 1996 | 4 |
About Pedro E. Cruz
Pedro E. Cruz is a scholar working on Genetics, Neurology, Genetics, Molecular Biology and Biological Psychiatry, having authored 126 papers that have together received 4.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (33 papers), Viral Infectious Diseases and Gene Expression in Insects (28 papers), Alzheimer's disease research and treatments (16 papers), RNA Interference and Gene Delivery (14 papers), CRISPR and Genetic Engineering (11 papers), Mesenchymal stem cell research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Nerve injury and regeneration (8 papers). The work is most often cited by research in Neurology (581 citations), Biological Psychiatry (147 citations), Genetics (588 citations), Physiology (878 citations) and Genetics (907 citations). Pedro E. Cruz has collaborated with scholars based in United States, Portugal and Germany. Frequent co-authors include Manuel J.T. Carrondo, Paula M. Alves, Todd E. Golde, Terence R. Flotte, Awilda M. Rosario, Carolina Ceballos‐Diaz, Paramita Chakrabarty, Cristina Peixoto, Hélder Cruz and Jorge M. Santos. Their work appears in journals such as Human Gene Therapy, Journal of Biotechnology, Molecular Therapy, Biotechnology Progress and Biotechnology and Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.